DEMO Employees voluntarily participated in Blood Donation 10 years Blood Bank
For the 10th consecutive year, on Friday 8th April, the pharmaceutical industry DEMO organized the Voluntary Blood Donation Day for its employees.…
2015 | a year of success for DEMO S.A.
DEMO SA pharmaceutical industry welcomed 2016 with wishes for a productive new year. The event for the celebration of the New Year, which took place…
Christmas celebration for the children of the company’s employees and message of support to the refugees by sending them relief items
Christmas spirit came to life at the DEMO’s premises in Kryoneri, Attica, where the Company’s Christmas Celebration took place with guests the…
DEMO’s Awards for its business performance
The successful business course of the Greek pharmaceutical company DEMO SA stands out as well as it is acknowledged. The company received two major…
DEMO S.A. sponsors the “Pablo Picasso-Jean Cocteau, The Modernist Innovators” Exhibition
DEMO SA , which supports our country’s culture and young people’s contact with the global works of art, is the key sponsor of the Exhibition “Pablo…
DEMO SA’s family celebrates its 50th anniversary
It was fifty years ago when Stavros Demos opened a pharmacy, which has evolved into the biggest pharmaceutical company in the domestic hospital…
DEMO S.A is certified member of TRACE
DEMO S.A is certified member of the internationally recognized organization TRACE, which works together with companies to promote and ensure…
Teicoplanin DCP registration proceeds as planned
DEMO Pharmaceutical Industry S.A. today announced the pan-european registration of its Teicoplanin injection product (Talinac) is proceeding as…
DEMO S.A. announces the inauguration of its new dedicated penem facility
DEMO S.A. today announced the inauguration of its brand new production facility for carbapenems. The new facility has been designed in accordance…
Meropenem DCP registration proceeds as planned
DEMO Pharmaceutical Industry S.A. today was informed by the UK regulatory authorities that its pan-european registration of its Meropenem injection…